Impact of SLCO 1B1 Pharmacogenetic Testing on Patient and Healthcare Outcomes: A Systematic Review-Reference-Cited by-同舟云学术

Impact of SLCO 1B1 Pharmacogenetic Testing on Patient and Healthcare Outcomes: A Systematic Review

Author:

Vassy Jason L.¹²³,Chun Sojeong¹⁴,Advani Sanjay¹,Ludin Sophie A.¹⁵,Smith Jason G.¹,Alligood Elaine C.¹

Affiliation:

1. Veterans Affairs (VA) VA Boston Healthcare System Boston Massachusetts USA

2. Harvard Medical School Boston Massachusetts USA

3. Division of General Internal Medicine and Primary CareBrigham and Women's Hospital Boston Massachusetts USA

4. Massachusetts College of Pharmacy and Health Sciences University Boston Massachusetts USA

5. Cornell University Ithaca New York USA

Funder

U.S. Department of Veterans Affairs

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

Reference86 articles.

3. US Food and Drug Administration.Table of pharmacogenomic biomarkers in drug labels. (2018). Accessed 1 March 2018.

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献